MENU
EWTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Edgewise Therapeutics (EWTX) Ownership - Who owns Edgewise Therapeutics?
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more
Profile
Industry
N/A
Address
1715 38th Street
Phone
+1 720 262-7002
Employees
88
Web
https://www.edgewisetx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.62B
P/E Ratio
N/A
Total Cash
470.17M
Projected Growth
N/A
Total Debt
4.74M
Revenue
N/A
Risk (Beta)
0.59
Dividend Yield
N/A
Total Cash/Share
4.47
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
EWTX
Capitalization
1.62B
P/E Ratio
N/A
Risk (Beta)
0.59
Dividend Yield
N/A
Total Cash
470M
Total Cash/Share
4.47
Total Debt
4.74M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
459M
P/B Ratio
3.53
Cash Flow
N/A
Earnings
-1.45
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
9K
Current Ratio
19.93
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-156.54M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-32.37
Shares Held By Institutions
3.28B
Shares Outstanding - Current
105M
Total Liabilities
27.6M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-42.322
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
1715 38th Street
Phone
+1 720 262-7002
Employees
88
Web
https://www.edgewisetx.com